质子泵抑制剂治疗功能性消化不良研究进展(4)
[25] Mayanagi S，Kishino M，Kitagawa Y，et al.Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy[J].Tohoku J Exp Med，2014，234(3)：237-240.
[26] Jaruvongvanich V，Poonsombudlert K，Ungprasert P.Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers：a systematic review and meta-analysis[J].European journal of gastroenterology & hepatology，2018，30(12)： 1416-1421.
[27] Asaoka D，Nagahara A，Hojo M，et al.Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis，non-erosive reflux disease，and functional dyspepsia[J].Biomed Rep，2017，6(2)：175-180.
[28] Tomita T，Oshima T，Miwa H，et al.New Approaches to Diagnosis and Treatment of Functional Dyspepsia[J].Curr Gastroenterol Rep，2018，20(12)：55.
[29] Shan J，Lei H，Shi W，et al.High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury[J].Dig Dis，2018，36(1)：66-71.
[30] Auesomwang C，Maneerattanaporn M，Chey WD，et al.Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication[J].Journal of gastroenterology and hepatology，2018，33(11)：1822-1828.
[31] 劉军浩，康海锋，李海燕，等.预先使用雷贝拉唑对幽门螺杆菌根除率影响的研究[J].胃肠病学，2013，18(3)：360-362., http://www.100md.com(宁琳 韦良宏 黄映莲)
[26] Jaruvongvanich V，Poonsombudlert K，Ungprasert P.Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers：a systematic review and meta-analysis[J].European journal of gastroenterology & hepatology，2018，30(12)： 1416-1421.
[27] Asaoka D，Nagahara A，Hojo M，et al.Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis，non-erosive reflux disease，and functional dyspepsia[J].Biomed Rep，2017，6(2)：175-180.
[28] Tomita T，Oshima T，Miwa H，et al.New Approaches to Diagnosis and Treatment of Functional Dyspepsia[J].Curr Gastroenterol Rep，2018，20(12)：55.
[29] Shan J，Lei H，Shi W，et al.High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury[J].Dig Dis，2018，36(1)：66-71.
[30] Auesomwang C，Maneerattanaporn M，Chey WD，et al.Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication[J].Journal of gastroenterology and hepatology，2018，33(11)：1822-1828.
[31] 劉军浩，康海锋，李海燕，等.预先使用雷贝拉唑对幽门螺杆菌根除率影响的研究[J].胃肠病学，2013，18(3)：360-362., http://www.100md.com(宁琳 韦良宏 黄映莲)